Yes. The IVDR was published in May 2017 and became applicable in May 2022, replacing the previous In Vitro Diagnostic Directive (IVDD).
During the transition period, manufacturers of in vitro diagnostic medical devices were given time to ensure compliance with the new IVDR requirements. The transition period can vary, but for most IVDs the transition period is five years from the date of application of the IVDR, which meant until May 2022. However, high-risk devices (Class D) and self-testing devices (Class B) have slightly different transition periods. Overall though, most manufacturers should be implementing the requirement or risk losing access to the EU market.